Craig-Hallum raised the firm’s price target on Astera Labs (ALAB) to $125 from $105 and keeps a Buy rating on the shares. Astera had “another strong report and guide,” driven by its Aries retimer products and exposure to key internal ASIC programs, the analyst tells investors. Calendar 2025 should be “another strong year,” driven by Gen 6 retimers and Scorpio P and X series, with help from Taurus and Leo product ramps, the analyst added in a post-earnings note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB:
- Astera Labs, Inc.’s Robust Growth Potential Driven by Strategic Acquisitions and Performance Metrics
- Astera Labs price target raised to $120 from $100 at Deutsche Bank
- Astera Labs price target raised to $123 from $110 at Evercore ISI
- Astera Labs, Inc.: Strong Buy Rating Supported by Product Diversification and Promising Growth Prospects
- Astera Labs, Inc.: Balancing Growth Opportunities with Rising Expenses – A Hold Rating Analysis